Given this association, there is growing interest in strategies to raise adiponectin levels through interventions such as peroxisome proliferator-activated receptor gamma (PPARγ) agonists or vigorous aerobic exercise as potential therapeutic approaches in obesity-related diseases and cancers [73]. The gene discussed is ADIPOQ; the disease is cancer.